Skip to content

LSD: all studies

Page 88 of 282: studies 871 to 880 of 2,815, newest first. Back to the LSD overview

Research

ZEN AND LSD: AN ENLIGHTENING EXPERIENCE

PSYCHOLOGIA 1964 Arthur H. Rogers

BLrlliChristianity must in the same way leave behind the Virgin Birth, the divinity of Christ, the existence or non-existence of God.These things may and should all be kept as symbols, not of ineffable mysteries, but of our own virginity, our own divinity, our own existence, and our own non-existence.Zen is the poetry of life, and all poetry is the same, all poetry is different.The joy at the...

A Working Paper: Memo on the Religious Implications of the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin)

Journal for the Scientific Study of Religion 1964 Joseph Havens 5 citations

Joseph Havens, A Working Paper: Memo on the Religious Implications of the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin), Journal for the Scientific Study of Religion, Vol. 3, No. 2 (Spring, 1964), pp. 216-226

Blockade of 5-Hydroxytryptamine Antidiuresis in Rats by 2-Bromlysergic Acid Diethylamide Tartrate and 1-Methyl-Lysergic Acid Butanolamide

Journal of Pharmacy and Pharmacology September 1, 1963 A Chodera

Abstract The effects of two lysergic acid derivatives, 2-bromlysergic acid diethylamide ‘BOL 148’ and 1-methyl-lysergic acid butanolamide ‘UML 491’ on the antidiuresis induced by 5-hydroxytryptamine ‘5-HT’ has been studied in rats given a dose of 1 mg./kg. 5-HT subcutaneously. BOL 148, 5 mg./kg., and UML 491, 2·5 mg./kg., counteracted the induced antidiuresis. By contrast, the antidiuretic...

Treatment of Chronic Alcoholism with Lysergic Acid Diethylamide

Canadian Psychiatric Association Journal June 1, 1963 S.E. Jensen, Ronald Ramsay

In this paper we have described some aspects of the LSD-25 treatment given to alcoholics in Weyburn, Saskatchewan. The three main therapeutic reactions discussed are (1) abreaction, (2) the transcendental experience and (3) break-down of inappropriate defence mechanisms. Some case histories are given to illustrate these therapeutic reactions and to give an idea of the kind of person who can be...

Differential Behavioral Responsivity to LSD-25

Archives of General Psychiatry June 1, 1963 Donald M. Krus 15 citations

The major question posed in this report is whether chronic schizophrenics show less psychologic response to the administration of a given dosage of lysergic acid diethylamide (LSD-25) than do normal adults. Data relevant to this question are of importance in at least three ways: (1) they are of relevance in delineating the mechanism of action of LSD insofar as such mechanisms—whether...

DOI: 10.1001/archpsyc.1963.01720120031005 (opens in new tab) Lysergic acid diethylamide Schizophrenia object-oriented programming Relevance law Action physics +4

Prolonged Adverse Reactions to Lysergic Acid Diethylamide

Archives of General Psychiatry May 1, 1963 Sidney Cohen 105 citations

Recently the authors1briefly reported complications and misuses associated with hallucinogenic drugs, such as D-lysergic acid diethylamide (LSD). Recently, an increasing number of adverse reactions to these drugs have occurred, and a discussion of the nature of the complications appears indicated. It is not our intention to minimize the potential value of these agents. Rather, we wish to...

Lysergic Acid Diethylamide (LSD-25) and Ego Functions

Archives of General Psychiatry May 1, 1963 Gerald D. Klee 60 citations

In 1947, Stoll32in Switzerland reported on the effects of D-lysergic acid diethylamide (LSD-25), an ergot derivative which can produce profound psychological effects in humans when it is given in minute doses. Since that time, a large volume of literature has grown up around this substance. LSD has been put to many uses. Its chemical interactions within the body have been studied with the as...

Permissive Group Therapy with Lysergic Acid Diethylamide

The British Journal of Psychiatry 1963 A. M. Spencer 21 citations

Lysergic acid diethylamide (LSD) has been used at Powick Hospital since 1952. During the early years of the treatment it became apparent that many of the dramatic psychic manifestations of the drug, including the vivid hallucinatory experiences, sensory hyperacuity, etc., were of no therapeutic value and that the chief use of the drug lay in its ability to bring into consciousness repressed...

A Controlled Trial of Abreaction with Lysergic Acid Diethylamide (Lsd-25)

The British Journal of Psychiatry 1963 J. Robinson, Lyndon Davies, E. L. N. S. Sack et al. 18 citations

All who have used lysergic acid diethylamide (LSD-25) acclaim it as a valuable aid to psychotherapy, regarding it as a “deep” abreactive agent, in that in certain cases it erupts early traumatic experiences as far back as infancy, with appropriate emotional catharsis which is believed to be of considerable therapeutic benefit to the patient. It is also claimed that it facilitates and enhances...